Unknown

Dataset Information

0

Exploring the inhibitory potentials of Momordica charantia bioactive compounds against Keap1-Kelch protein using computational approaches.


ABSTRACT: The search for Keap1 inhibitors as potential Nrf2 activator is a way of increasing the antioxidant status of the human cellular environ. In this research, we used in silico methods to investigate Keap1-kelch inhibitory potential of Momordica charantia's bioactive compounds in order to predict their Nrf2 activating potential. ADMET profiling, physicochemical properties, molecular docking, molecular dynamics, and Molecular Mechanics-Poisson Boltzmann Surface Area (g_MMPBSA) free energy calculation studies were executed to drive home our aim. Out of all the bioactive compounds of Momordica charantia, catechin (CAT) and chlorogenic acid (CGA) were selected based on their ADMET profile, physicochemical properties, and molecular docking analysis. Molecular docking studies of CAT and CGA to Keap1 kelch domain showed that they have - 9.2 kJ/mol and - 9.1 kJ/mol binding energies respectively with CAT having four hydrogen bond interactions with Keap1 while CGA had three. Analysis after the 30 ns molecular dynamics simulation revealed that CAT and CGA were both stable, although with minimal conformational alterations at the kelch pocket of Keap1. Finally, MMPBSA calculation of the Gibbs free energy of each amino acid interaction with CAT and CGA revealed that CAT had a higher total binding energy than CGA. Therefore, the Keap1 inhibitory capacities and the molecular dynamic characters of CAT and CGA at the Kelch domain of Keap1 suggest a putative Nrf2 signaling activating prowess.

Supplementary information

The online version contains supplementary material available at 10.1007/s40203-021-00100-2.

SUBMITTER: Adelusi TI 

PROVIDER: S-EPMC8233444 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature

altmetric image

Publications

Exploring the inhibitory potentials of <i>Momordica charantia</i> bioactive compounds against Keap1-Kelch protein using computational approaches.

Adelusi Temitope Isaac TI   Abdul-Hammed Misbaudeen M   Idris Mukhtar Oluwaseun MO   Kehinde Oyedele Qudus OQ   Boyenle Ibrahim Damilare ID   Divine Ukachi Chiamaka UC   Adedotun Ibrahim Olaide IO   Folorunsho Ajayi Ayodeji AA   Kolawole Oladipo Elijah OE  

In silico pharmacology 20210625 1


The search for Keap1 inhibitors as potential Nrf2 activator is a way of increasing the antioxidant status of the human cellular environ. In this research, we used in silico methods to investigate Keap1-kelch inhibitory potential of <i>Momordica charantia's</i> bioactive compounds in order to predict their Nrf2 activating potential. ADMET profiling, physicochemical properties, molecular docking, molecular dynamics, and Molecular Mechanics-Poisson Boltzmann Surface Area (g_MMPBSA) free energy calc  ...[more]

Similar Datasets

| S-EPMC9023165 | biostudies-literature
| S-EPMC7253571 | biostudies-literature
| PRJDB15174 | ENA
| PRJNA495866 | ENA
| PRJNA1057972 | ENA
| PRJNA808187 | ENA
| PRJNA1031990 | ENA
| PRJNA702876 | ENA
| PRJNA1012561 | ENA
| PRJDB1471 | ENA